News | News By Subject | News by Disease News By Date | Search News

Cystic fibrosis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Tiny Massachusetts Phenom Corbus (CRBP) Plunges Despite Reporting Positive Phase II CF Data     3/30/2017
Vertex (VRTX) Inks Deal Worth $250 Million for Concert Pharma (CNCE)'s Cystic Fibrosis Drug     3/6/2017
Anthera Pharma (ANTH) Plunges After Cystic Fibrosis Drug Fails Late-Stage Trial     12/29/2016
A Crucial Need for Symptomatic Treatments Still Exists for Cystic Fibrosis Patients     12/5/2016
After Hep C Flop, Has Vertex (VRTX) Learned From Its Past Mistakes?     10/18/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected     9/22/2016
Vertex (VRTX) Dumps Phase III Cystic Fibrosis Study     8/17/2016
Vertex (VRTX) and Moderna Hammer Out $315 Million+ Deal to Treat Cystic Fibrosis Using mRNA Technology     7/6/2016
FDA Spurns Vertex (VRTX) Application for Expanded Use of Kalydeco     2/5/2016
How Vertex (VRTX)'s Long-Term $500K Gamble Paid Off with a $30 Billion Return     11/18/2015
Vertex (VRTX)'s Success Spurs Startups Corbus and Pulmatrix to Enter Cystic Fibrosis Market     8/18/2015
Watch Out Gilead (GILD), Investors Feel Vertex (VRTX) May Be Biogen (BIIB)'s Good Fit     8/4/2015
Vertex (VRTX) Gets FDA Approval for $259K Per Year CF Drug     7/7/2015
Vertex (VRTX) Poised to Become Profitable Following Expected FDA Approval of Orkambi     7/1/2015
Tiny Parion Sciences Wrangles Lung Pact Worth $1.2 Billion From Vertex (VRTX)     6/8/2015

News from Around the Web
Wearable Sweat Sensor Could Help Diagnose Diseases Like Diabetes, Cystic Fibrosis, Stanford University Study     4/18/2017
Is Vertex (VRTX)'s New CF Drug Unprecedented? Incremental? Expensive? Maybe All Three     3/30/2017
New Life Form Discovered In Saliva Is Linked To Human Disease, University of Washington Study     6/27/2016
VisiVest, A New Connected High-Frequency Chest-Wall Oscillation System, Hill-Rom Reveals     6/22/2016
The Importance Of Implementing CF Newborn Screening Reinforced, McGill University Study     5/5/2016
Researchers Build Promising CF Diagnostic System Using Microsoft's Xbox Kinect Sensors     3/30/2016
Fast, Accurate Cystic Fibrosis Test Developed At Stanford University     2/2/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Garlic Could Help Cure Lung Infection, University of Edinburgh Study     2/25/2015
University of Pittsburgh-Led Study Suggests Cystic Fibrosis Is Two Diseases, One Doesn’t Affect Lungs     7/23/2014
Cystic Fibrosis And Diabetes Link Explained, Lund University Study     6/3/2014
New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study     11/8/2012
Sea Sponge Chemical Fixes Cystic Fibrosis Defect, McGill University Study     10/29/2012
Differences Seen in Lung Microbes of Cystic Fibrosis Patients, Stanford University Study     10/1/2012
Big Advance Against Cystic Fibrosis: Stem Cell Researchers Create Lung Surface Tissue in a Dish, Massachusetts General Hospital Study     4/6/2012

Press Releases
Spyryx Biosciences Reports Positive Data On SPX-101 At American Thoracic Society International Conference     5/24/2017
Vertex (VRTX) Awards 40 Scholarships Totaling $200,000 To People Living With Cystic Fibrosis And Their Immediate Family Members     5/19/2017
Anthera Announces First Patient Screened In RESULT Pivotal Phase III Clinical Study Of Sollpura     5/16/2017
The American Journal Of Respiratory And Critical Care Medicine Publishes Study Of Spyryx Biosciences' SPX-101, A Novel Enac-Targeted Therapeutic For Cystic Fibrosis That Restores Mucus Transport     5/9/2017
Vertex (VRTX) Grants $1 Million To 15 Non-Profit Organizations To Advance Initiatives For People Living With Cystic Fibrosis     5/4/2017
Laurent Receives FDA And Health Canada Clearance To Initiate APPLAUD Phase II Clinical Study Of LAU-7b For The Treatment Of Cystic Fibrosis     4/19/2017
Wearable Sweat Sensor Could Help Diagnose Diseases Like Diabetes, Cystic Fibrosis, Stanford University Study     4/18/2017
Protalix Biotherapeutics, Inc. (PLX) Announces Positive Results From Phase II Clinical Trial Of Alidornase Alfa (AIR Dnase) For The Treatment Of Cystic Fibrosis     4/12/2017
George Washington University Release: Research Uncovers Potential New Treatment To Treat And Stop Progression Of Cystic Fibrosis     4/11/2017
Spyryx Biosciences Presents Data And Corporate Update At Two Recent Conferences In Support Of Clinical Candidate For Cystic Fibrosis     4/5/2017
Vertex (VRTX) Gains Nearly $4 Billion In Market Cap As New Cystic Fibrosis Drug Wows In Two Phase III Studies     3/29/2017
Cystic Fibrosis Research Assays Are The Latest Additions To Canon BioMedical's Novallele Genotyping Library     3/7/2017
Mast Therapeutics (MSTX) Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients     3/6/2017
Vertex (VRTX) To Acquire CTP-656 From Concert Pharma (CNCE) For The Treatment Of Cystic Fibrosis     3/6/2017
PTC Therapeutics (PTCT) Ditches Cystic Fibrosis Drug After Trial Failure     3/2/2017

//-->